Aravasc's Grant

Aravasc raised a round of funding on July 10, 2006. Investors include National Science Foundation.

Aravasc is a company that received a SBIR Phase I grant for a project entitled: Drug Eluting Stents to Treat Obstructed Tracheo-Bronchial Lumen Due to Lung Cancer. Their research project will demonstr…

Articles about Aravasc's Grant: